ZimVie Wins Investigational Device Exemption For Disc Replacement Device, Plans To Begin Study

The US FDA has granted Investigational Device Exemption to Colorado life sciences company ZimVie for its cervical disc implant. The approval means the company can begin enrolling patients in a study to further evaluate the device.